aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed Aug 12, 2015 · 10-Q · 43 days after period end · 0001193125-15-288119
| Metric | Q2 2015 | Q2 2014 |
|---|---|---|
| Net Income | -$11.08M | -$5.59M |
| EPS Diluted | -$0.74 | -$6.85 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 12, 2015 · 43 d after period end
